AIP
CAPR icon

Ameritas Investment Partners’s Capricor Therapeutics CAPR Stock Holding History

Ameritas Investment Partners’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$118K Buy
4,881
+1,315
+37% +$39.9K ﹤0.01% 1732
2026
Q1 		$108K Buy
3,566
+319
+10% +$8.5K ﹤0.01% 1651
2025
Q4 		$93.7K Sell
3,247
-585
-15% -$7.64K ﹤0.01% 1745
2025
Q3 		$27.6K Hold
3,832
– – ﹤0.01% 2526
2025
Q2 		$38.1K Hold
3,832
– – ﹤0.01% 2357
2025
Q1 		$36.4K Hold
3,832
– – ﹤0.01% 2279
2024
Q4 		$52.9K Buy
3,832
+1,345
+54% +$23.6K ﹤0.01% 2145
2024
Q3 		$37.8K Hold
2,487
– – ﹤0.01% 2349
2024
Q2 		$11.9K Buy
+2,487
New +$13.9K ﹤0.01% 2863

Other funds holding CAPR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Ameritas Investment Partners's CAPR Position: Q2 2026 in Review

Ameritas Investment Partners increased its Capricor Therapeutics (CAPR) stake by 37% in Q2 2026, buying an estimated $39.9K and bringing the position to 4,881 shares worth $118K. The position accounts for ﹤0.01% of the portfolio, ranked #1732.

Ameritas Investment Partners first reported a position in CAPR in Q2 2024 and has held it in 9 quarters since. 169 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

  • Ameritas Investment Partners held 4,881 shares of Capricor Therapeutics worth $118K as of Q2 2026.
  • Ameritas Investment Partners bought 1,315 Capricor Therapeutics shares in Q2 2026, an estimated $39.9K.
  • Capricor Therapeutics made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #1732 holding.
  • Ameritas Investment Partners first reported a position in Capricor Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • 169 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.